Help for FIP

For those who use WhatsApp as a communication tool for friends and family, news or information, we have a channel dedicated strictly to Feline Infectious Peritonitis supportive care, treatment, tips, and education.

Regardless of how you treat or where you’re located, supportive care is vital and every bit as important to your cat’s survival as the drugs themselves.

Everyone is invited to follow: https://whatsapp.com/channel/0029Vb9IR1d9xVJcmfbwko2S

Help and Education for Cats with Feline Infectious Peritonitis (FIP) by Help for FIP™️ - WhatsApp channel Follow Help and Education for Cats with Feline Infectious Peritonitis (FIP) by Help for FIP™️'s WhatsApp Channel. Get safe, fast, research-centered, compassionate guidance from a team that prioritizes the urgency of an FIP diagnosis and provides ongoing support tailored to your cat, because no "one-size-fits-all" treatment plan works for FIP. www.helpforfip.com. Follow us on Facebook: https://www.facebook.com/HELPForFIP. Join 57 followers for the latest updates.

Weekly Wins July 13-Aug 3, 2026.

What you should know about Abdominal Effusion

"What was your cat's response time to treatment in the first two weeks??

One of the most common questions and concerns we get from parents is, "When will my cat show improvement?" Or "Why did my cat seem better yesterday than today"? And the other big one: "I see posts all the time about how fast others' cats responded to treatment, but my cat seems to be taking longer".

It's hard to not compare your case to others you read on social media. There are so many variables to consider — acuity, other pathogens or diseases, age, whether treatment was delayed, the severity of neurological symptoms (seizures, blindness, paralysis), level of supportive care (thermoregulation, appetite assistance, hydration), hospitalization vs. at home stabilization, the use of low-dose prednisolone, whether treatment started with oral or injectable GS-441524 (or IV Remdesivir in countries where available) if/when critical. These are just some of the many factors that can influence response speed.

We hope this timeline clarifies what most (not all) early responses to anti-viral therapy will look like. If there is little or no improvement by the end of two weeks, it's time for a deeper dive with your vet to consider other differential diagnoses or more aggressive treatment (partial effusion drains, higher GS dosing or route change, feeding tube, to name a few).

One of the most heartbreaking situations we face—multiple times every day—is a family unable to afford the enormous veterinary bills associated with a critically ill cat.

Every week, we communicate for endless hours with families whose cats are crashing and ultimately pass away because they could not afford thousands of dollars in emergency care. It is gut-wrenching to know what a cat needs but are mostly powerless. Occasionally, after many hours of virtual guidance, we can help a family provide basic supportive care at home and save the cat, but when a cat is critically ill, at-home stabilization attempts are usually not enough. Again, this is because parents often can't afford thousands to seek the help of an ER.

Although FIP can be strongly suspected from a cat's history, symptoms, examination, and basic blood work, families may be encouraged to pursue extensive diagnostics before treatment begins. X-rays, ultrasounds, MRIs, PCR testing, specialty consultations, emergency visits, and hospitalization for stabilization can quickly push the total cost to $10,000 or more. A trial of FIP treatment is generally only a few hundred — an affordable option for most, but one that is rarely suggested.

The antiviral medication used to treat FIP—GS-441524 and, in some countries, remdesivir or molnupiravir—is the most affordable part of the entire process as long as you learn which pharmacies offer reasonable pricing and where to find experienced, safe, research-followed guidance if you must wait for delivery (delays) as most practices do not stock the antivirals, which is actually the biggest issue we're facing today.

When the evidence strongly points to FIP, treatment should not be needlessly delayed. A properly dosed, closely monitored two-week antiviral trial (injections work best as learned by nearly a decade of tracking responses and outcomes across the various FIP groups--and yes, your vet CAN prescribe them, even if they say they can't--combined with appropriate veterinary supportive care) can provide powerful clinical evidence. Depending on the cat's condition, supportive care may include warming, assisted feeding, hydration, prednisolone, anti-nausea or appetite-support medications, and medications for pain or seizures.

FIP antivirals are well tolerated, and cats with FIP often respond well when treatment starts promptly. Beginning treatment while continuing to evaluate other possible diagnoses may be safer and far more affordable than waiting days or weeks for additional testing while a cat continues to decline.

If your cat's symptoms, test results, your research, and your instincts all point toward FIP—but your veterinarian will not prescribe treatment or immediately recommends euthanasia—seek another opinion. Find a veterinarian who will work with you, or ask us for a referral to a supportive veterinarian in your area.

Since prescription-compounded GS-441524 became available in mid-2024, we have seen far too many cats decline or die while families were "waiting for medication," "waiting for test results," or trying to find thousands of dollars they had been told treatment would cost. Others spent everything they had on diagnostics and had nothing left for treatment or lifesaving stabilization.

Too many families contact us when it is already too late. That is what drove me to write this post, and it's maddening that we can't get these statistics into the hands of those who have the influence or power to push for change...and we need to talk about it, especially the ongoing push from vets to euthanize.

Do not let unnecessary delays, misinformation about cost, or a lack of resources prevent you from advocating for your cat. Start asking questions, seek experienced help, and begin fundraising as early as possible.

I sincerely hope this list of fundraising ideas — and why treatment should not be delayed — helps more families advocate for and afford the veterinary care and treatment their cats need, and gives more FIP cats a chance to survive.

https://doi.org/10.3390/ani16121851

𝗜𝗻 𝗰𝗮𝘁𝘀 𝘄𝗶𝘁𝗵 𝗙𝗜𝗣 𝗿𝗲𝗰𝗲𝗶𝘃𝗶𝗻𝗴 𝗚𝗦-𝟰𝟰𝟭𝟱𝟮𝟰, 𝟯𝟱.𝟯% 𝘄𝗲𝗿𝗲 𝗯𝗲𝗹𝗼𝘄 𝘁𝗵𝗲 𝗽𝗿𝗼𝗽𝗼𝘀𝗲𝗱 𝗺𝗶𝗻𝗶𝗺𝘂𝗺 𝘁𝗮𝗿𝗴𝗲𝘁, 𝟮𝟵.𝟰% 𝘄𝗲𝗿𝗲 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝘁𝗵𝗲 𝗺𝗶𝗻𝗶𝗺𝘂𝗺 𝗮𝗻𝗱 𝗼𝗽𝘁𝗶𝗺𝗮𝗹 𝘁𝗮𝗿𝗴𝗲𝘁𝘀, 𝗮𝗻𝗱 𝟯𝟱.𝟯% 𝗿𝗲𝗮𝗰𝗵𝗲𝗱 𝘁𝗵𝗲 𝗽𝗿𝗼𝗽𝗼𝘀𝗲𝗱 𝗼𝗽𝘁𝗶𝗺𝗮𝗹 𝘁𝗮𝗿𝗴𝗲𝘁.

GS-441524 has transformed the prognosis of feline infectious peritonitis (FIP), but we still have relatively limited information about how much drug actually reaches the circulation of individual cats.

A new 2026 study developed and validated an LC-MS/MS method for measuring GS-441524 concentrations in feline serum, then applied it to 17 cats undergoing treatment for confirmed FIP.

The results were striking.

Serum GS-441524 concentrations ranged from 0.34 to 21.80 µM, with a median of 5.0 µM.

Using previously proposed therapeutic targets of >3.0 µM as a minimum target and >10.0 µM as an optimal target:

• 35.3% of cats were below the minimum target
• 29.4% were above the minimum but below the optimal target
• 35.3% reached the proposed optimal target

The study also found that serum concentrations were positively associated with both the administered dose and duration of treatment.

Interestingly, cats receiving injectable GS-441524 had significantly higher serum concentrations than cats receiving oral formulations.

But there was an important caveat: serum drug concentration did not neatly predict inflammatory status. Three cats had GS-441524 concentrations below the proposed minimum target while their serum amyloid A (SAA) was within the reference interval.

The researchers also independently tested the five compounded GS-441524 formulations used in the study. All contained drug concentrations within ±15% of their labelled claims, suggesting that the variation in serum concentrations was unlikely to be explained solely by inadequate drug content.

𝗪𝗵𝘆 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗮𝘁𝘁𝗲𝗿?

The findings highlight how much individual pharmacokinetic variability may influence GS-441524 exposure. Dose alone may not tell us exactly how much drug a particular cat is actually exposed to.

The authors propose that validated therapeutic drug monitoring (TDM) could eventually help move FIP treatment toward a more individualized approach.

However, this was a small preliminary study involving only 17 cats, with samples collected at varying stages of treatment and 2–3 hours after dosing. The authors specifically caution that the proposed therapeutic targets should not yet be considered definitive reference ranges.

Still, this is an important step toward understanding what happens to GS-441524 after we give it to the cat.

Study cited in the comments